| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Animal: RNA Viruses |
Institute for Animal Health, Pirbright Laboratory, Pirbright, Surrey GU24 0NF, UK1
Author for correspondence: Edmund Walsh. Fax +44 1483 232 448. e-mail phil.walsh{at}bbsrc.ac.uk
In order to effectively control and eliminate rinderpest, a method is required to allow serological differentiation between animals that have been vaccinated and those which have recovered from natural infection. One way of doing this would be to engineer the normal vaccine to produce a genetically marked rinderpest virus (RPV) vaccine. We constructed two modified cDNA clones of the RPV RBOK vaccine strain with the coding sequence of the green fluorescent protein (GFP) gene inserted as a potential genetic marker. RPVINS-GFP virus was designed to produce independent and high level expression of GFP inside infected cells, whilst the GFP expressed by RPVSIG-GFP virus was designed to be efficiently secreted. Infectious recombinant virus was rescued in cell culture from both constructs. The effectiveness of these viruses in stimulating protective immunity and antibody responses to the marker protein was tested by vaccination of cattle and goats. All of the vaccinated animals were completely protected when challenged with virulent virus: RPV in cattle or peste-des-petits ruminants virus in the goats. ELISA showed that all of the animals produced good levels of anti-RPV antibodies. Three of the four cattle and the two goats vaccinated with RPVSIG-GFP produced detectable levels of anti-GFP antibodies. In contrast, no anti-GFP antibodies were produced in the four cattle and two goats vaccinated with RPVINS-GFP. Therefore, secretion of the GFP marker protein was absolutely required to elicit an effective humoral antibody response to the marker protein.
This article has been cited by other articles:
|
|
 |
|
  S. Parida, M. Mahapatra, S. Kumar, S. C. Das, M. D. Baron, J. Anderson, and T. Barrett Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine J. Gen. Virol., July 1, 2007; 88(7): 2019 - 2027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Huang, S. Elankumaran, A. S. Yunus, and S. K. Samal A Recombinant Newcastle Disease Virus (NDV) Expressing VP2 Protein of Infectious Bursal Disease Virus (IBDV) Protects against NDV and IBDV J. Virol., September 15, 2004; 78(18): 10054 - 10063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Sola, S. Alonso, S. Zuniga, M. Balasch, J. Plana-Duran, and L. Enjuanes Engineering the Transmissible Gastroenteritis Virus Genome as an Expression Vector Inducing Lactogenic Immunity J. Virol., April 1, 2003; 77(7): 4357 - 4369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Neumann, M. A. Whitt, and Y. Kawaoka A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned? J. Gen. Virol., November 1, 2002; 83(11): 2635 - 2662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Wertz, R. Moudy, and L. A. Ball Adding Genes to the RNA Genome of Vesicular Stomatitis Virus: Positional Effects on Stability of Expression J. Virol., June 27, 2002; 76(15): 7642 - 7650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Walsh, M. D. Baron, L. F. Rennie, P. Monaghan, J. Anderson, and T. Barrett Recombinant Rinderpest Vaccines Expressing Membrane-Anchored Proteins as Genetic Markers: Evidence of Exclusion of Marker Protein from the Virus Envelope J. Virol., November 1, 2000; 74(21): 10165 - 10175. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
